Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.
about
Coagulation syndrome: Delayed perforation after colorectal endoscopic treatmentsCalf and forearm blood flow in hypercholesterolemic patientsCoronary microcirculation in health and disease. Summary of an NHLBI workshop.Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.Coronary spastic angina induced by anticholinesterase medication for myasthenia gravis--a case report.In vivo assessment of endothelial function in human lower extremity arteriesNitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.Inflammatory and thrombotic mechanisms in coronary atherosclerosisEffect of cholesterol lowering treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms.Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy.Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases.Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms.Angiogenesis in human coronary atherosclerotic plaques.Focal impairment in myocardial fatty acid imaging in the left anterior descending artery area, a strong predictor for cardiac death in hemodialysis patients without obstructive coronary artery diseaseHypothyroidism Is Associated With Coronary Endothelial Dysfunction in Women.Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular riskThe role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation.Nitric oxide function in atherosclerosisTechniques to harvest diseased human peripheral arteries and measure endothelial function in an ex vivo model.Biopterin status in dogs with myxomatous mitral valve disease is associated with disease severity and cardiovascular risk factors.Effects of exercise training and hypercholesterolemia on adenosine activation of voltage-dependent K+ channels in coronary arterioles.Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusionTypical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve.Enhanced K(+)-channel-mediated endothelium-dependent local and conducted dilation of small mesenteric arteries from ApoE(-/-) mice.Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.Augmented agonist-induced Ca(2+)-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells.The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions?Endothelial dysfunction in the coronary microcirculation: a new clinical entity or an experimental finding?Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism.Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats.Off-pump coronary bypass surgery causes less immediate postoperative coronary endothelial dysfunction compared to on-pump coronary bypass surgery.Exercise training improves conduit vessel function in patients with coronary artery disease.Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations.Comparison of resistance and conduit vessel nitric oxide-mediated vascular function in vivo: effects of exercise training.Association of Low Ficolin-Lectin Pathway Parameters with Cardiac Syndrome X.Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans
P2860
Q26784245-3BDCF8BA-F880-421A-936F-5A9BFE108D4CQ28377505-F6FA3DDB-2DE6-4C5B-A39E-AF21C40FDF1AQ30412920-CC112B3F-2FDA-4936-A6E2-2957B7CDAF36Q30813656-07623DFD-237B-426F-B5C0-EE4DBD28B3F7Q31758593-8583F920-EB02-45C6-9ADA-C3403D55F110Q33970913-C114BF92-584F-4AD4-9060-98C01ABEFB00Q34209867-F90C6B31-FF4B-4AE5-A66E-647E4A2A8F12Q35055194-E40A5241-B171-45DB-8BA5-FD0A2F23EDABQ35201247-D2A42429-F25A-4EB1-8418-B0837C2DE199Q35373901-A16092EE-8DC5-4E6F-8068-C4D356163893Q35579449-F461B010-615D-431F-B316-8705C7AF8D31Q35696305-1569904A-BB55-4786-BEF5-B44BF0455E61Q35820618-2046D21C-4952-4B9E-9E34-6C3CB687EEABQ35833812-ADFF1C7B-496D-4C20-B9F8-36A5FB909BDDQ35905522-EDC604BB-64CE-4480-89BF-74C74AB482C1Q36141677-FDA62166-3906-432D-ACD1-508722FCBCBBQ36405147-BE65971A-AE25-4EAC-AB50-C51B393A2A66Q36536154-A7A043CA-3DAE-4E37-9274-96CEF6AB1F09Q36628207-577CA1F8-A45B-44ED-9A95-D3FED203B4A3Q36816957-9C519053-19FC-434E-B44E-DFDB546CE398Q36975420-820CB3DA-63D9-45FC-8269-67FA9F8CACD9Q37033552-C428FDF6-3081-427A-A682-BC9DD6C2AAD7Q37633905-3CF2713F-13F1-4B60-8612-AF89A292F3ECQ38671970-CD73797C-0B34-442B-BF8C-19FCFE9711D4Q38711902-FC55052A-5915-4F0C-A904-391926BE65BBQ39776974-68271E49-9AEC-4DEF-8CB8-A865AB7DE744Q40340818-2C1362E3-AB1B-4603-A7AD-C484A50C4598Q40452360-A83AE99D-2D83-4E43-AEE8-B93CEB4FA92BQ40512562-E0B743A1-DB91-4549-BB1C-0F480C38C970Q42105037-F1A2BBC7-EB4E-48A5-9228-9D3D8ACB9B5FQ43572784-B22B76A9-7825-47F1-9EE9-96CA3FACA300Q43805085-41D4467C-58D3-4BD6-9E93-FBE767F0BEB1Q44470169-BFEBFDD0-6EE3-48F2-B455-B0C3B0C0BF56Q44559057-D17E4B57-49FB-4E09-89C0-11C9F341D062Q44848201-429F96A4-81AB-4337-92D7-240A48A6D41FQ51699092-21D45F45-BA89-49AF-A60E-42F2E4DD0176Q58130073-FDC35FFE-9EC9-4B33-8B3D-445A9D354069
P2860
Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Impaired coronary blood flow r ...... ximal atherosclerotic lesions.
@ast
Impaired coronary blood flow r ...... ximal atherosclerotic lesions.
@en
type
label
Impaired coronary blood flow r ...... ximal atherosclerotic lesions.
@ast
Impaired coronary blood flow r ...... ximal atherosclerotic lesions.
@en
prefLabel
Impaired coronary blood flow r ...... ximal atherosclerotic lesions.
@ast
Impaired coronary blood flow r ...... ximal atherosclerotic lesions.
@en
P2093
P2860
P356
P1476
Impaired coronary blood flow r ...... ximal atherosclerotic lesions.
@en
P2093
Egashira K
Sugimachi M
Takeshita A
P2860
P356
10.1172/JCI116183
P407
P577
1993-01-01T00:00:00Z